Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Vaccine
|
August 11, 2015
The US FDA pregnancy lactation and labeling rule - Implications for maternal immunization
Marion F Gruber
Expert Review of Vaccines
|
August 3, 2011
US FDA review and regulation of preventive vaccines for infectious disease indications: impact of the FDA Amendments Act 2007
Marion F Gruber
Vaccine
|
July 10, 2003
Maternal immunization: US FDA regulatory considerations
Marion F Gruber
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 27, 2014
Global and national initiatives to facilitate studies of vaccines in pregnant women
Marion F Gruber
NPJ Vaccines
|
August 17, 2022
Current status of monkeypox vaccines
Marion F Gruber
Science (New York, N.Y.)
|
June 23, 2018
Evaluating human trials: FDA's role
Philip R Krause, Marion F Gruber
Expert Review of Vaccines
|
April 28, 2017
Regulating vaccines at the FDA: development and licensure of Zika vaccines
Marion F Gruber, Philip R Krause
Vaccine
|
January 10, 2015
Regulatory considerations in the clinical development of vaccines indicated for use during pregnancy
Jeffrey N Roberts, Marion F Gruber
Influenza and Other Respiratory Viruses
|
July 19, 2016
An overview of the regulation of influenza vaccines in the United States
Jerry P Weir, Marion F Gruber
The New England Journal of Medicine
|
October 16, 2020
Emergency Use Authorization of Covid Vaccines - Safety and Efficacy Follow-up Considerations
Philip R Krause, Marion F Gruber
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Vaccine
|
August 11, 2015
The US FDA pregnancy lactation and labeling rule - Implications for maternal immunization
Marion F Gruber
Expert Review of Vaccines
|
August 3, 2011
US FDA review and regulation of preventive vaccines for infectious disease indications: impact of the FDA Amendments Act 2007
Marion F Gruber
Vaccine
|
July 10, 2003
Maternal immunization: US FDA regulatory considerations
Marion F Gruber
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 27, 2014
Global and national initiatives to facilitate studies of vaccines in pregnant women
Marion F Gruber
NPJ Vaccines
|
August 17, 2022
Current status of monkeypox vaccines
Marion F Gruber
Science (New York, N.Y.)
|
June 23, 2018
Evaluating human trials: FDA's role
Philip R Krause, Marion F Gruber
Expert Review of Vaccines
|
April 28, 2017
Regulating vaccines at the FDA: development and licensure of Zika vaccines
Marion F Gruber, Philip R Krause
Vaccine
|
January 10, 2015
Regulatory considerations in the clinical development of vaccines indicated for use during pregnancy
Jeffrey N Roberts, Marion F Gruber
Influenza and Other Respiratory Viruses
|
July 19, 2016
An overview of the regulation of influenza vaccines in the United States
Jerry P Weir, Marion F Gruber
The New England Journal of Medicine
|
October 16, 2020
Emergency Use Authorization of Covid Vaccines - Safety and Efficacy Follow-up Considerations
Philip R Krause, Marion F Gruber
Page
of 3